| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | necrostatin-1 | CTRPv2 | pan-cancer | AAC | 0.053 | 0.2 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | -0.11 | 0.2 |
| mRNA | GDC-0941 | FIMM | pan-cancer | AAC | 0.23 | 0.2 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | -0.069 | 0.2 |
| mRNA | staurosporine | CTRPv2 | pan-cancer | AAC | -0.1 | 0.2 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | -0.07 | 0.2 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.072 | 0.2 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | 0.051 | 0.2 |
| mRNA | EX-527 | CTRPv2 | pan-cancer | AAC | -0.054 | 0.2 |